Integra LifeSciences
IART
223 hedge funds and large institutions have $2.96B invested in Integra LifeSciences in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 61 reducing their positions, and 41 closing their positions.
477% more call options, than puts
Call options by funds: $12M | Put options by funds: $2.08M
185.69% more ownership
Funds ownership: 0% → 185.69% (+186%)
56% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 61
8% more capital invested
Capital invested by funds: $2.75B → $2.96B (+$211M)
5% less funds holding
Funds holding: 234 → 223 (-11)
22% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 41
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$50.1M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$41.6M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$35.7M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$27.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$36.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$35.3M |
| 3 |
CCI
Columbus Circle Investors
|
-$25.7M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$20.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
251
Capstone Investment Advisors
New York
| – | -$321K | -7,800 | Closed |
|
|
SCP
252
Syntal Capital Partners
Midland,
Texas
| – | -$317 | -7,694 | Closed |
|
253
Simplex Trading
Chicago,
Illinois
| – | -$302K | -7,430 | Closed |
|
254
Aviva
London,
United Kingdom
| – | -$248K | -6,000 | Closed |
|
255
Verition Fund Management
Greenwich,
Connecticut
| – | -$232K | -5,630 | Closed |
|
|
PP
256
Paloma Partners
Greenwich,
Connecticut
| – | -$218K | -5,294 | Closed |
|
|
SM
257
Sciencast Management
Princeton,
New Jersey
| – | -$215K | -5,200 | Closed |
|
|
JG
258
Jefferies Group
New York
| – | -$211K | -5,114 | Closed |
|
259
First Manhattan
New York
| – | -$117K | -2,848 | Closed |
|
260
Nomura Holdings
Tokyo,
Japan
| – | -$104K | -2,508 | Closed |
|
|
NIT
261
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$83K | -2,000 | Closed |
|
|
QT
262
Quantbot Technologies
New York
| – | -$64K | -1,558 | Closed |
|
|
MA
263
MUFG Americas
New York
| – | -$34K | -826 | Closed |
|
|
BL
264
Balentine LLC
Atlanta,
Georgia
| – | -$5K | -130 | Closed |
|
IART Hedge Fund Activity: Q4 2016 in Review
223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2016, worth a combined $2.96B — up 7.7% from $2.75B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of IART and 32 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 95 added.
The largest buyer was Invesco, adding an estimated $50.1M. The largest seller was Westwood Holdings Group, cutting an estimated $36.6M.
- 223 institutional investors held Integra LifeSciences (IART) as of Q4 2016, down from 234 in Q3 2016.
- Funds reported $2.96B of Integra LifeSciences stock for Q4 2016, up 7.7% quarter-over-quarter.
- 32 funds opened new Integra LifeSciences positions in Q4 2016 and 41 closed out, a net change of -9 holders.
- The largest Integra LifeSciences buyer in Q4 2016 was Invesco, an estimated $50.1M added.
- The largest Integra LifeSciences seller in Q4 2016 was Westwood Holdings Group, an estimated $36.6M sold.
Based on aggregated 13F filings for Q4 2016.